Davinci Laboratories

Cranberry 400 mg

F
N+ Score45
Vitamins & MineralsServing: 1 Capsule(s)Type: Botanical

Davinci Laboratories Cranberry 400 mg is a single-ingredient botanical supplement, providing 400 mg of cranberry fruit juice powder per capsule. Cranberry is widely recognized and researched for its potential to support urinary tract health. While 400 mg is a common dosage for general cranberry supplementation, research often focuses on standardized extracts with specific proanthocyanidin (PAC) content, and higher dosages or specific PAC concentrations are sometimes used in studies for more pronounced effects. This product has an N+ Score of 45, resulting in an F grade and placing it in the below-average tier. The score reflects a 50% ingredient adequacy and 0% formula completeness, which is expected for a single-ingredient product. The label provides 100% transparency, clearly stating the cranberry dosage. This product may be considered by individuals seeking a basic cranberry supplement for general wellness.

About This Product

Cranberry 400 mg by Davinci Laboratories is a vitamins & minerals supplement containing 1 active ingredients. It has earned an N+ Score of 45/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity36/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed

Weaknesses

  • −Missing several expected ingredients for its category
  • −Limited ingredient diversity compared to category norms

Ingredient Analysis (1 ingredients)

IngredientAmountDose Adequacy
Cranberry fruit juice powder400.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.